Pacer Advisors, Inc.

Position in CPRX — Catalyst Pharmaceuticals, Inc.

CIK 1616667 Malvern, PA

Position in CPRX

as of Mar 31, 2026 · filed Jun 18, 2026 Compact

Position Value

$8,958,019

-$231,709 QoQ

Shares Held

361,794

-8.1% QoQ

Ownership

0.296%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Pacer Advisors, Inc. holds $745,075,920 across 25 Biotechnology names. CPRX ranks #8 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	358,633	$277,094,201
2	INCY	Incyte Corp	1,741,061	$163,868,661
3	JAZZ	Jazz Pharmaceuticals plc	503,013	$95,094,607
4	EXEL	Exelixis, Inc.	1,549,611	$66,462,815
5	VRTX	Vertex Pharmaceuticals Inc / Ma	88,863	$39,680,884
6	RPRX	Royalty Pharma plc	689,194	$33,060,636
7	HALO	Halozyme Therapeutics, Inc.	295,524	$19,099,716
8	CPRX	Catalyst Pharmaceuticals, Inc. This page	361,794	$8,958,019

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,958,019	361,794	-8.1%	Shares	Sole	2026-06-18
2025-12-31	$9,189,728	393,733	-36.6%	Shares	Sole	2026-02-24
2025-09-30	$12,229,779	620,801	-3.8%	Shares	Sole	2025-10-15
2025-06-30	$13,999,364	645,132	-24.5%	Shares	Sole	2025-08-12
2025-03-31	$20,718,399	854,367	-71.1%	Shares	Sole	2025-05-06
2024-12-31	$61,681,451	2,955,508	+5.4%	Shares	Sole	2025-01-22
2024-09-30	$55,743,778	2,804,013	-5.5%	Shares	Sole	2024-11-12
2024-06-30	$45,967,736	2,967,575	+130918.8%	Shares	Sole	2024-08-13
2024-03-31	$36,104	2,265	-99.6%	Shares	Sole	2024-05-10
2023-03-31	$8,517,709	513,734	+4933.6%	Shares	Sole	2023-05-02
2021-03-31	$47,049	10,206	+18.6%	Shares	Sole	2021-04-05
2020-12-31	$28,750	8,608	-7.9%	Shares	Sole	2021-01-20
2020-09-30	$27,754	9,345	—	Shares	Sole	2020-10-19
No filing history on record for this holder in this stock.